首页> 美国卫生研究院文献>Biochemical Journal >Microbiological degradation of bile acids further degradation of a cholic acid metabolite containing the hexahydroindane nucleus by Corynebacterium equi.
【2h】

Microbiological degradation of bile acids further degradation of a cholic acid metabolite containing the hexahydroindane nucleus by Corynebacterium equi.

机译:胆汁酸的微生物降解马氏棒杆菌进一步降解含有六氢茚满核的胆酸代谢物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The further degradation of a cholic acid (I) metabolite, (4R)-4-[4alpha-(2-carboxyethyl)-3aalpha-hexahydro-7abeta-methyl-5-oxoindan-1beta-yl]valeric acid (IIa), by Corynebacterium equi was investigated. This organism effected ring-opening and gave (4R)-4-[2alpha-(2-carboxyethyl)-3beta-(3-carboxypropionyl)-2beta-methylcyclopent-1beta-yl]valeric acid (VI). The new metabolite was isolated as its trimethyl ester and identified by partical synthesis. It was not utilized by C. equi. 2. (4R)-4[4alpha-(2-Carboxyethyl)-3aalpha-decahydro-8abeta-methyl5-oxa-6-oxoazulen-1beta-yl]valeric acid (IVa), which is a hypothetical initial oxidation product in the above degradation, was not converted by C. equi into the expected metabolite (VI), but into 3 - [2beta - [(2S) - tetrahydro - 5 - oxofur - 2 - yl] - 1beta - methyl - 5 - oxocyclopent - 1alpha - yl]-propionic acid (VIII), the structure of which was established by partial synthesis. 3. Both the possible precursors of the metabolite (VI), an isomer of the epsilon-lactone (IVa), the gamma-lactone (XIa), and the open form of these lactones, the hydroxytricarboxylic acid (V), were also not utilized by C. equi. 4. Under some incubation conditions, C. equi also converted compound (IIa) and 3-(3aalpha-hexahydro-7abeta-methyl-1,5-dioxoindan-4alpha-yl)propionic acid (IIb) into 5-methyl-4-oxo-octane-1,8-dioic acid (III), (4R)-4-(2,3,4,6,6abeta,7,8,9,9aalpha,9bbeta-decahydro-6abeta-methyl-3-oxo-1H-cyclopenta[f]quinolin-7beta-yl)valeric acid (VII) and probably a monohydroxy derivative of compound (IIa) and compound (III), respectively. 5. The possibility that an initial step in the degradation of compound (IIa) by C. equi is oxygenation of the Baeyer-Villiger type, yielding compound (IVa), is discussed. Metabolic pathways of compound (IIa) to compounds (III), (VI), (VII) and (VIII) are also considered.
机译:1.胆酸(I)代谢物(4R)-4- [4α-(2-羧乙基)-3aalpha-六氢-7abeta-甲基-5-氧代茚满-1beta-基]戊酸(IIa)的进一步降解,由马科杆菌进行了调查。该生物进行开环反应,得到(4R)-4- [2α-(2​​-羧乙基)-3β-(3-羧基丙酰基)-2β-甲基环戊-1β-基]戊酸(VI)。分离出新的代谢产物为其三甲酯,并通过部分合成进行鉴定。马齿。没有利用它。 2.(4R)-4 [4α-(2-羧乙基)-3aalpha-十氢-8abeta-甲基5-oxa-6-恶唑啉-1beta-基]戊酸(IVa),其为以上假设的初始氧化产物降解,不是由马尾梭菌转化为预期的代谢物(VI),而是转化为3-[2beta-[(2S)-四氢-5-氧氟草酸-2-yl]-1beta-甲基-5-氧代环戊-1α-基]丙酸(VIII),其结构是通过部分合成确定的。 3.代谢物(VI)的可能的前体,ε-内酯(IVa)的异构体,γ-内酯(XIa)以及这些内酯的开放形式羟基三羧酸(V)都没有由C. equi使用。 4.在某些孵育条件下,马鞭毛衣藻还将化合物(IIa)和3-(3aalpha-六氢-7abeta-甲基-1,5-二氧杂茚满-4α-基)丙酸(IIb)转化为5-甲基-4-氧辛烷-1,8-二酸(III),(4R)-4-(2,3,4,6,6abeta,7,8,9,9aalpha,9bbeta-十氢-6abeta-甲基-3-氧代-1H-环戊[f]喹啉-7β-基)戊酸(VII),可能是化合物(IIa)和化合物(III)的单羟基衍生物。 5.讨论了通过马鞭毛虫降解化合物(IIa)的初始步骤是Baeyer-Villiger型氧合产生化合物(IVa)的可能性。还考虑了化合物(IIa)到化合物(III),(VI),(VII)和(VIII)的代谢途径。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号